ArticleOman journal of ophthalmology

Twenty-four-month real-world visual outcomes of intravitreal aflibercept as monotherapy for the treatment of neovascular age-related macular degeneration.

Thomas Siempis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.